Tag Archives: Supreme Court

The Yin and Yang of the Court Decision on HCR

by Tom Norton If you’re like me, you probably bounded out of bed on Thursday morning, took in all the news you could find about the Supreme Court and healthcare reform…and then you waited.  You waited patiently for the biggest legal call in American healthcare history.  And then, there it was. What did we learn?  […]
Posted in FDA, healthcare, leadership, Legal, Market Access, Regulatory, Strategy | Also tagged , , , | 1 Comment

HCR and the Supreme Court: Three Important Days in March

The Supreme Court will open up deliberations on the constitutionality of three important parts of healthcare reform (HCR) this month. by Tom Norton After nearly two years of legal wrangling, on November 14, 2011 the Supreme Court (SCOTUS) determined that as a result of contradictory US Appellate Courts findings on the Patient Protection and Affordable […]
Posted in healthcare, Legal, Strategy | Also tagged , , , | Leave a comment

Supreme Court Strikes down Vermont Law, Upholds Rep Free Speech

June 23rd was a good day for the pharmaceutical industry. The Supreme Court released two decisions that largely went pharma’s way. There was much rejoicing across the industry, and for good reason, business as usual won out. In PLIVA v. Mensing, the Court ruled that generic drug companies should comply with federal regulations instead of […]
Posted in Legal | Also tagged , , | Leave a comment

Supreme Court Ruling Makes Generics More Dangerous

Today’s Supreme Court ruling on Pliva v. Mensing, which held that generic drug companies are not responsible for updating drug labels in light of new safety concerns, makes taking generic drugs a riskier proposition for consumers, Justice Sonia Sotomayor wrote in her dissenting opinion. Justices Stephen Breyer, Elena Kagan and Ruth Bader Ginsburg also dissented […]
Posted in Corporate Responsibility, Legal | Also tagged | 1 Comment

Preemption Watch: You've Been Warned

The Supreme Court on Wednesday issued its decision in the much-watched case of Wyeth v. Levine—which many in pharma hoped would firmly establish FDA decisions as a bulwark against common-law liability suits in state courts. The decision, as you’ve no doubt heard already, went against Wyeth. Pharm Exec‘s coverage is here. The opinion is here. […]
Posted in Legal | Also tagged , , | 6 Comments
  • Categories

  • Meta